A Kent and Medway Cancer Network (KMCN) audit of second-line treatment for non-small cell lung cancer

被引：0
|
作者：
Cafferkey, C. [1 ]
Jamal-Hanjani, M. [1 ]
Beesley, S. [1 ]
Cominos, M. [1 ]
Sevitt, T. [1 ]
Taylor, H. [1 ]
Burcombe, R. [1 ]
Shah, R. [1 ]
机构：
[1] Maidstone Hlth Author, Maidstone, Kent, England
来源：
LUNG CANCER | 2010年 / 67卷
关键词：
D O I：
10.1016/S0169-5002(10)70022-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
21
引用
收藏
页码：S7 / S8
页数：2
相关论文
共 50 条
  • [21] Second-line chemotherapy in the treatment of advanced non-small cell lung cancer (NSCLC)
    Ardizzoni, A
    Tiseo, M
    JOURNAL OF CHEMOTHERAPY, 2004, 16 : 104 - 107
  • [22] Second-Line Chemotherapy and Beyond for Non-Small Cell Lung Cancer
    Durm, Greg
    Hanna, Nasser
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (01) : 71 - +
  • [23] Considerations for second-line therapy of non-small cell lung cancer
    Stinchcombe, Thomas E.
    Socinski, Mark A.
    ONCOLOGIST, 2008, 13 : 28 - 36
  • [24] SECOND-LINE THERAPY FOR ADVANCED NON-SMALL CELL LUNG CANCER
    Cullen, M.
    LUNG CANCER, 2009, 64 : S13 - S13
  • [25] Second-line treatment of small cell lung cancer
    Schmittel, A.
    Sebastian, M.
    Niederle, N.
    ONKOLOGE, 2013, 19 (11): : 940 - +
  • [26] Second-line Treatment of Non-Small Cell Lung Cancer: Focus on the Clinical Development of Dacomitinib
    Zugazagoitia, Jon
    Diaz, Asuncion
    Jimenez, Elisabeth
    Nunez, Juan Antonio
    Iglesias, Lara
    Ponce-Aix, Santiago
    Paz-Ares, Luis
    FRONTIERS IN MEDICINE, 2017, 4
  • [27] Biweekly Vinorelbine and Gemcitabine as Second-Line Treatment and Beyond in Non-Small Cell Lung Cancer
    Chelis, L.
    Xenidis, N.
    Amarantidis, K.
    Prassopoulos, P.
    Chamalidou, E.
    Neanidis, K.
    Mikroulis, D.
    Chatzaki, E.
    Karakitsos, P.
    Kakolyris, S.
    CHEMOTHERAPY, 2010, 56 (05) : 353 - 358
  • [28] Influence of Radiotherapy in Second-Line Treatment with Immunotherapy in Patients with Non-Small Cell Lung Cancer
    Azkona, E.
    Carrera, S.
    Rubio, I.
    Mane, J. M.
    Lacambra, I.
    Sancho, A.
    Novo, E.
    Lopez-Vivanco, G.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S969 - S969
  • [29] Second-line treatment options in advanced non-small cell lung cancer: Current status
    Cullen, M
    SEMINARS IN ONCOLOGY, 2006, 33 (01) : S3 - S8
  • [30] Weekly docetaxel as a second-line treatment for advanced non-small cell lung cancer (NSCLC).
    García, R
    Pérez, P
    Alfonso, R
    Pérez-Manga, G
    Díaz-Rubio, E
    ANNALS OF ONCOLOGY, 2000, 11 : 116 - 116
12345